As of 2024-07-27, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (10.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.43 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -218.7%.
The range of the Relative Valuation is (7.52) - (10.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 14.7x | 10.2x |
| Forward P/E multiples | 10.1x - 20.5x | 16.7x |
| Fair Price | (7.52) - (10.95) | (10.01) |
| Upside | -189.2% - -229.9% | -218.7% |
| Date | P/E |
| 2024-07-26 | -11.33 |
| 2024-07-25 | -11.13 |
| 2024-07-24 | -10.63 |
| 2024-07-23 | -10.82 |
| 2024-07-22 | -10.56 |
| 2024-07-19 | -10.55 |
| 2024-07-18 | -10.41 |
| 2024-07-17 | -10.75 |
| 2024-07-16 | -11.29 |
| 2024-07-15 | -11.33 |
| 2024-07-12 | -10.92 |
| 2024-07-11 | -10.21 |
| 2024-07-10 | -9.62 |
| 2024-07-09 | -8.67 |
| 2024-07-08 | -8.95 |
| 2024-07-05 | -8.96 |
| 2024-07-03 | -8.99 |
| 2024-07-02 | -8.98 |
| 2024-07-01 | -8.95 |
| 2024-06-28 | -9.19 |
| 2024-06-27 | -9.08 |
| 2024-06-26 | -8.91 |
| 2024-06-25 | -8.81 |
| 2024-06-24 | -8.77 |
| 2024-06-21 | -8.40 |
| 2024-06-20 | -8.17 |
| 2024-06-18 | -7.38 |
| 2024-06-17 | -7.39 |
| 2024-06-14 | -7.73 |
| 2024-06-13 | -6.77 |
| 2024-06-12 | -6.62 |
| 2024-06-11 | -6.75 |
| 2024-06-10 | -6.69 |
| 2024-06-07 | -6.64 |
| 2024-06-06 | -6.99 |
| 2024-06-05 | -7.38 |
| 2024-06-04 | -7.12 |
| 2024-06-03 | -7.40 |
| 2024-05-31 | -7.66 |
| 2024-05-30 | -7.79 |
| 2024-05-29 | -7.89 |
| 2024-05-28 | -7.97 |
| 2024-05-24 | -7.79 |
| 2024-05-23 | -7.79 |
| 2024-05-22 | -8.06 |
| 2024-05-21 | -8.20 |
| 2024-05-20 | -8.45 |
| 2024-05-17 | -8.29 |
| 2024-05-16 | -8.43 |
| 2024-05-15 | -8.45 |